PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Completed

Phase 4 Results

Main Contacts

Name Phone E-mail
Luc Sagnard Study Director

Other Locations

Name City State Country Status
Sanofi-Aventis Natanya Israel Unknown_status_icon
Sanofi-Aventis Istanbul Turkey Unknown_status_icon
Sanofi-Aventis North Ryde Australia Unknown_status_icon
Sanofi-Aventis Vienna Austria Unknown_status_icon
Sanofi-Aventis Milan Italy Unknown_status_icon
Sanofi-Aventis Warsaw Poland Unknown_status_icon
Sanofi-Aventis Bridgewater New Jersey United States Unknown_status_icon
Sanofi-Aventis Sao Paulo Brazil Unknown_status_icon
Sanofi-Aventis Laval Canada Unknown_status_icon
Sanofi-Aventis Bogota Colombia Unknown_status_icon
Sanofi-Aventis Prague Czech Republic Unknown_status_icon
Sanofi-Aventis Mumbai India Unknown_status_icon
Sanofi-Aventis Seoul Korea, Republic of Unknown_status_icon
Sanofi-Aventis Mexico Mexico Unknown_status_icon
Sanofi-Aventis Johannesburg South Africa Unknown_status_icon